Testicular Cancer

Testicular cancer is characterized by abnormal cell growth and replication in the testes, the male sex glands responsible for producing sperm and androgens.

Quick Answer

What it is

Testicular cancer is characterized by abnormal cell growth and replication in the testes, the male sex glands responsible for producing sperm and androgens.

Key findings

No graded findings are available yet.

Safety

No specific caution or interaction language was detected in the current summary/outcome notes.

ℹ️ Quick Facts

Quick Facts: Testicular Cancer

  • Supplements Studied:0
0 supps · 0 outcomes

Evidence-Based Protocol

Supplement stack ranked by research quality

Limited Evidence

Primary Stack (Tier 1)

2000-4000 IU daily (monitor levels; target 40-60 ng/mL)

Supports immune function during cancer treatment; deficiency common in cancer patients

15 studies | 2,000 participants
1-2g dried ginger daily, starting before chemotherapy

Effective for chemotherapy-induced nausea and vomiting

12 studies | 1,500 participants

Supporting Stack (Tier 2)

2-3g EPA+DHA daily

Anti-inflammatory; may help maintain muscle mass and reduce treatment side effects

15 studies | 1,500 participants
20-50 billion CFU daily (Lactobacillus, Bifidobacterium strains)

Support gut health during chemotherapy; may reduce GI side effects

12 studies | 1,000 participants
10-30g daily in divided doses (consult oncologist)

May reduce chemotherapy-induced mucositis and peripheral neuropathy

10 studies | 800 participants
100-300mg daily

May protect against chemotherapy cardiotoxicity; supports cellular energy

8 studies | 500 participants
2-3g daily

May reduce cisplatin-induced nephrotoxicity and fatigue

8 studies | 400 participants
100-200mcg daily (do not exceed)

Antioxidant that may support immune function during treatment; avoid high doses

6 studies | 400 participants

How It Works

Testicular cancer is one of the most treatable cancers, with cure rates exceeding 95% even when spread. It primarily affects young men (ages 15-35). Treatment typically includes surgery (orchiectomy to remove the affected testicle) and may involve chemotherapy (especially cisplatin-based regimens like BEP) and/or radiation depending on the type and stage. While highly curable, treatments can cause significant side effects including nausea, fatigue, neuropathy, kidney effects, and long-term concerns about fertility and hormone levels.

CRITICAL: Testicular cancer treatment should ONLY be managed by an oncology team - typically a urologic oncologist and medical oncologist. The high cure rate depends on proper treatment. Do NOT delay or modify cancer treatment based on supplements. These supplements are for SUPPORTIVE CARE to help manage treatment side effects and support recovery - they are not cancer treatments. ALWAYS discuss supplements with your oncologist BEFORE taking them, as some may interfere with chemotherapy effectiveness. Fertility preservation (sperm banking) should be discussed BEFORE treatment.

* Vitamin D deficiency is common in cancer patients and optimizing levels may support immune function and bone health during treatment.

* Ginger has good evidence for reducing chemotherapy-induced nausea and vomiting when used alongside standard antiemetics.

* Omega-3 Fatty Acids have anti-inflammatory effects and may help maintain muscle mass during treatment.

* Probiotics help maintain gut health during chemotherapy and may reduce diarrhea.

* Glutamine may help reduce mucositis (mouth sores) and potentially peripheral neuropathy from chemotherapy.

* Coenzyme Q10 may provide some cardioprotection during chemotherapy.

* L-Carnitine may help protect kidneys from cisplatin toxicity and reduce fatigue.

* Selenium supports antioxidant defenses but should be used cautiously and not in high doses during active treatment.

Expected timeline: Supplements for side effect management start around treatment initiation. Recovery and follow-up extends for years (surveillance for recurrence). Long-term survivorship care is important.

Generated from peer-reviewed researchSchema v2.0